CTSB and pancreatitis: Several investigations support the cathepsin B-dependent proteolytic activation of trypsinogen in experimental pancreatitis since depletion of CTSB in a knockout model or by pharmacological treatment markedly abolished trypsinogen activation and pancreatic damage [2, 8, 20].